Next Article in Journal
Isolation and Characterization of One New Natural Compound with Other Potential Bioactive Secondary Metabolites from Glycosmis cyanocarpa (Blume) Spreng. (Family: Rutaceae)
Next Article in Special Issue
Structure Elucidation of Two Intriguing Neo-Debromoaplysiatoxin Derivatives from Marine Cyanobacterium Lyngbya sp. Showing Strong Inhibition of Kv1.5 Potassium Channel and Differential Cytotoxicity
Previous Article in Journal
Electro-Oxidative C3-Selenylation of Pyrido[1,2-a]pyrimidin-4-ones
Previous Article in Special Issue
Monkfish (Lophius litulon) Peptides Ameliorate High-Fat-Diet-Induced Nephrotoxicity by Reducing Oxidative Stress and Inflammation via Regulation of Intestinal Flora
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 5
10.3390/molecules28052204
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Recent Advances of Marine Natural Indole Products in Chemical and Biological Aspects

by
Haoyi Sun
1,†,
Kangping Sun
1,† and
Jingyong Sun
1,2,3,*
1
School of Parmacy and Pharmaceutical Sciences, Institute of Materia Medical, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China
2
NHC Key Laboratory of Biotechnology Drugs, Shandong Academy of Medical Sciences, Jinan 250117, China
3
Key Laboratory for Rare & Uncommon Discases of Shandong Province, Jinan 250117, China
*
Author to whom correspondence should be addressed.
†
These authors contributed to the work equally.
Molecules 2023, 28(5), 2204; https://doi.org/10.3390/molecules28052204
Submission received: 29 January 2023 / Revised: 16 February 2023 / Accepted: 23 February 2023 / Published: 27 February 2023
(This article belongs to the Special Issue Theme Issue Honoring Professor Peter Proksch’s 70th Birthday: Bioactive Compounds from Nature Products)
Browse Figures
Review Reports Versions Notes

Abstract

:
The ocean has always been one of the important sources of natural products. In recent years, many natural products with different structures and biological activities have been obtained, and their value has been clearly recognized. Researchers have been deeply engaged in the field of separation and extraction, derivative synthesis, structural studies, biological evaluation, and other fields of research for marine natural products. Thus, a series of marine indole natural products which have structural and biological prospect have caught our eyes. In this review, we summarize some of these marine indole natural products with relatively good pharmacological activity and research value, and discuss issues concerning chemistry, pharmacological activity, biological evaluation, and synthesis, including monomeric indoles, indole peptides, bis-indoles, and annelated indoles. Most of the compounds have cytotoxic, antiviral, antifungal, or anti-inflammatory activities.

1. Introduction

The marine environment has been explored for the purpose of searching for new bioactive compounds over the past 50 years, becoming an important and rich source of potent molecules and lead compounds. Alkaloids, which constitute one of the largest classes of natural products, are synthesized by terrestrial and marine organisms on all evolutionary levels, usually present in organisms as mixtures consisting of several major and a few minor compounds. These compounds have the same biosynthetic source, and the differences only appear in functional groups.
This class of compounds has apparently evolved as a defense mechanism against predators, and as a result, alkaloids are often highly potent and toxic molecules [1]. Marine invertebrates have proven to be an outstanding source of active molecules, one of the most promising being indole alkaloids.
Indole alkaloids, their activity, synthesis, and potential use in medicine have already been reviewed in several articles [2]. In this review, we provide information on current and potential pharmaceuticals including small molecule marine indole alkaloids, their biological properties, and structure-activity relationship studies.

2. Monomeric Indoles and Annelated Indoles

Jiang et al. isolated two new alkaloids, phidianidines A (1) and B (2) (Figure 1), from the marine opisthobranch mollusk Phidiana militaris. They are the first natural products with 1,2,4-oxadiazole ring system, which show strong antitumor activity against C6 and Hela cells, with IC50 values in the nanomolar range [3], and they were synthesized for the first time by Guo et al. (Scheme 1). Compound 1 and synthetic analogues showed immunosuppressive properties [4]. In addition, compound 1 was also shown to be a selective inhibitor of the dopamine transporter and a selective, potent ligand and partial agonist of the μ-opioidreceptor (versus δ- and κ-opioid receptors) [5]. In addition, by using virtual screening and experimental method, compound 1 was considered as a new antagonist of CXCR4 which is a chemokine receptor associated with several diseases such as HIV, rheumatoid arthritis, and cancer [6]. Compound 1 is also a potent natural antifoulant and its structure can be tuned to generate simpler and improved synthetic analogues [7].
Five new indole-terpenoids named penerpenes E–I (3–7) were isolated from the marine-derived fungus Penicillium sp. KFD28 from a bivalve mollusk, Meretrix lusoria, among them, compounds 3, 4, and 6 exhibited inhibitory activity against PTP1B with IC50 values of 14, 27, and 24 μM. Compound 3 also inhibited PTP sigma with an IC50 of 38 μM, while compound 6 inhibited TCPTP with IC50 values of 35 μM, respectively [8].
In 2020, two new compounds named epipaxilline 8 and penerpene J were isolated from the marine-derived fungus Penicillium sp. KFD28 by Chen et al. Compounds 8 and 9 showed inhibitory activities against PTP1B with IC50 values of 31.5 and 9.5 μM, respectively, and compound 9 also showed inhibitory activities against TCPTP with IC50 value of 14.7 μM [9].
With the aid of genomic analysis, eight indole-diketopiperazines, including three new compounds, spirotryprostatin G (10) and cyclotryprostatins F and G (11–12), were obtained by large-scale cultivation of the marine-derived fungus Penicillium brasilianum HBU-136 using rice medium with 1.0% MgCl2. In addition, compound 10 proved to be active against HL-60 cell line with the IC50 value of 6.0 μM, whereas compounds 11 and 12 are active against McF-7 cell line with the IC50 values of 7.6 and 10.8 μM, respectively [10] (Figure 1).
Discodermindole (13a) and 6-hydroxydiscodermindole (13b), isolated from the Bahama sponge Discodermia polydiscus, and trachycladindoles A-G (14a–g), isolated from the South Australian sponge Trachycladus laevispirulifer, belong to the rather limited class of indole alkaloids containing a 2-aminoimidazoline substituent at position 3. In addition, they all, with the exception of compound 14g, have one or more bromine atoms in their structure, which is common for many secondary metabolites of marine origin [11,12,13] (Figure 2).
Convoluindole A (15) was isolated from the cosmopolitan species Amathia convoluta Lamouroux (order Ctenostomata) from the Gulf of Mexico off the coast of Florida, as a pale yellow oil which crystallized after storage at −30 °C overnight, m.p. 61.5–62.5 °C. The molecular formula was determined by high-resolution liquid second ion mass spectrometry to be C14H17Br3N2O2. In agreement with this assignment, the isotope pattern was characteristic of a tribrominated compound [14].
In 2020, four new indole diterpenoids, ascandinines A-D (16–19), were isolated from an Antarctic sponge-derived fungus Aspergillus candidus HDN15-152 by Zhou et al. Ascandinine A (16) possesses an unprecedented 2-oxabicyclo [2.2.2]octan-3-ol motif embedded in a pentacyclic ring system, while ascandinines B–D (17–19) represent a rare type of indole diterpenoid featuring the 6/5/5/6/6/6/6-fused ring system. Ascandinine C (18) displayed anti-influenza virus A (H1N1) activity with an IC50 value of 26 μM, while ascandinine D (19) showed cytotoxicity against HL-60 cells with an IC50 value of 7.8 μM [15] (Figure 3).
Meridianin A–G (20a–g) was discovered by Gompel et al. to be an effective inhibitor of various protein kinases, including casein kinase 1, glycogen synthase kinase-3, cyclic nucleotide-dependent kinases, and cyclin dependent kinases. Meridianins can penetrate cells and disrupt the function of kinases necessary for cell division and death. This results in the prevention of cell proliferation and the induction of apoptosis. These findings imply that meridianins represent a potentially useful framework for the development of more powerful and specific protein kinase inhibitors [16]. The synthesis of meridianin C, D, F, and G (20c, d, f, and g) (Scheme 2) via a one-pot Masuda borylation-Suzuki coupling sequence was recently introduced by Kruppa et al. [17].
From the boreal sponge Geodia barretti, which was discovered off the coast of Norway, several compounds were isolated, including barettin (21), 8,9-dihydrobarettin (22), 6-bromoconicamin (23), and a brand-new brominated marine indole. The compounds were evaluated as inhibitors of electric eel acetylcholinesterase. Compounds 21 and 22 displayed significant inhibition of the enzyme, with inhibition constants (Ki) of 29 and 19 µM, respectively, towards acetyl cholinesterase via a reversible noncompetitive mechanism [18].
Indole derivatives including new bromoindoles have been isolated from the South Pacific marine sponges Rhopaloeides odorabile and Hyrtios sp. Their potential cytotoxic, antioxidant, and phospholipase A2 (PLA2) inhibiting properties were valued. The new derivative 5,6-dibromo-L-hypaphorine (24) isolated from Hyrtios sp. revealed a weak bee venom PLA2 inhibition (IC50 = 0.2 mM) and a significant antioxidant activity with an Oxygen Radical Absorbance Capacity (ORAC) value of 0.22 [19].
A novel indole diterpene known as penicindopene A (25) was discovered in the Penicillium sp. YPCMAC1 deep-sea mold. Containing IC50 values of 15.2 and 20.5 µmol, respectively, compound 25 was the first instance of an indole diterpene with a 3-hydroxyl-2-indolone moiety, and it showed mild cytotoxicities against the A549 and HeLa cell lines [20].
From the Red Sea sponge Hyrtios sp., Youssef et al. (2013) discovered three novel alkaloids, hyrtioerectines D-F (26a–c). The rare marine alkaloids known as hyrtioerectines D-F (26a–c) have a C-3/C-3 linkage between the indole and β-carboline moiety of the molecule. Variable antibacterial, free radical scavenging, and cancer growth suppression properties were shown by hyrtioerectines D-F (26a–c). According to Table 1 [21], compounds 26a and b were more active than compound 26c (Figure 4).
Fumigatosides E (27a) and F (27b), two novel alkaloids, were discovered in the deep-sea fungus Aspergillus fumigatus SCSIO 41012. Both compound 27a and compound 27b demonstrated strong antifungal activity against Fusarium oxysporum f. sp. momordicae with MIC values of 1.56 g/mL and 6.25 g/mL, respectively [22,23] (Figure 5).

3. Indolyl Peptides

Two N-acylanthranillic acids (28a,b), one of which is a new natural product, were isolated as co-metabolites of bacillamides (29a,b) and N-acetyltryptamine by Akiyama et al. using metabolome mining in a strain known as Laceyella sacchari. Anthranilic acid and Ac2O or propionyl chloride were combined to synthesis compounds 28a and 28b (Scheme 3), which were then tested for bioactivity and structure. The physicochemical properties of the synthetic 28a and 28b were essentially the same as those of the natural products [23].
While 28b, 29a, and 29b were initially discovered from Bacillaceae or Thermoactinomycetaceae-28b from Bacillus pantothenicus [24], 29a from a marine Bacillus sp. as an algicide selective to dinoflagellates and raphydophytes, and 29b from B. endophyticus [25]-compound 28a was isolated for the first time as a natural product (Figure 6).
A series of linearly fused prenylated indole alkaloids was isolated from Aspergillus versicolor, a fungus isolated from the mud of the South China Sea. (Figure 7) and of these compounds, asperversiamides A-C and E (30–32 and 34) each contain a rare anti-bicyclo [2.2.2] diazaoctane ring, and asperversiamide D (33) contains the analogous syn-ring (when the C21-C22 and C17-N13 bonds are cofacial, the ring is defined as “syn”, and when the C21-C22 and C17-N13 bonds are on opposite faces, the ring is considered “anti”) [26,27].
The first linearly fused indole alkaloid discovered with a rare fused-imine-containing pyrrole ring structure is asperversiamide A (30). Additionally, molecules 31, 32 and 33, 34 are corresponding pairings of C-3 and C-21 epimers. Asperversiamide G (36) has a unique Z-geometry of the double bond between C-10 and C-11, while asperversiamide F (35) is the C-17 epimer of dihydrocarneamide A (37) [28]. Compound 37, which has an isoprenyl unit at C-3 and is a key precursor of spiro-bicyclo [2.2.2] diazaoctane type indole alkaloids, is based on the biosynthesis route (31–32). By additional modification, co-isolated deoxybrevianamide E (38) might be used as a precursor to a number of structurally similar prenylated indole alkaloids [29].

4. Bis-Indole Alkaloids

Due to its strong biological activity and novel structural features, there is a strong interest in some bis-indole secondary metabolites containing spacer units derived from imidazole or piperazine, like hamacanthin A (39) and B (40) [30]. These two compounds, discovered by Gunasekera and his colleagues [31], are two isomeric bis-indole alkaloids isolated from the deep-sea species Hamacantha sp. Compound 39 is a 3,6-bis-indole derivative and is similar to dragmacidins, but compound 40 is 3,5-isomer, whose structure is rare among these alkaloids. Since these alkaloids are relatively rare in nature and difficult to extract, the importance of finding a method for total synthesis is apparent. In 2005, Takashi et al. reported the method of total synthesis of marine bisindole alkaloids, compounds 39 and 40 (Figure 8). Therein, they describe the total synthesis of compounds 39 and 40 via cyclization and transamidation of N-(2-aminoethyl)-2-oxoethanamide derived from (S)-indolylglycinol (Scheme 4) [32,33]. We can obtain similar compounds from many sources, including dihydro derivatives and debrominated derivatives [34].
Both compounds 39 and 40 show significant antimicrobial activity against Candida albicans ATCC 44506 and Cryptococcus neoformans ATCC 32045 with MIC value of 1.6–6.2 µg/mL [34]. However, compound 40 shows weak antibacterial activity against Candida albicans and the MIC is 25–100 µg/mL [35]. The activity of compound 39 is pretty strong (MIC, 0.78–3.12 µg/mL), especially against Methicillin-resistant Staphylococcus aureus (MIC, 3.12 µg/mL) and also has potent antifungal activity against Candida albicans (MIC, 6.25 µg/mL) [30,31].
Dragmacidin (41) was originally isolated from the deep-water marine sponge of dragmacidin sp., and later discovered from Hexadella sp. [36]. Along with it, several bis-indole compounds which have similar structure were discovered, including dragmacidin A (42) and B (43) [37,38]. A year later, Faulkner and co-workers isolated a new alkaloid named dragmacidin C (44) from the encrusting gray tunicate Didemnum candidum, which was collected in the southern Gulf of California [39].
Dragmacidin D (45) was found in a deep-water marine sponge called Spongosorites sp. that was obtained off the coast of southern Australia and had a rotational measurement of +12.5, according to Capon and colleagues [40]. A novel alkaloid known as dragmacidin E (46) was discovered in Spongosorites sp. that were gathered during a trawling operation off the southern coast of Australia. More recently, a marine sponge of the species Halicortex that was obtained in 2000 [41] off the southern coast of Utica Island, Italy, was shown to contain dragmacidin F (47)-a novel bioactive bromoindole alkaloid (Figure 9).
Due to their wide range of both biological and pharmacological activities, the necessity of the total synthesis is obvious. Jiang and co-workers reported the total synthesis of compound 41 [42] (Scheme 5). In the same year, Cava and co-workers reported a simple synthesis of compound 43 [43]. A short synthetic strategy for various bis-indole marine natural products, including compound 43, was described by Horne [44]. The first total synthesis of racemic compound 42 via indolyl glycines was accomplished by Kawasaki and co-workers, and the method could be applicable to the syntheses of other members of the dragmacidin family and analogues [45]. In 2005, the facile formal total synthesis of compounds 43 and 44 was reported [46]. The chiral bis-indole alkaloid compound 41 was reported to inhibit in vitro growth of P388 murine leukemia cells (IC50 = 15 µg/mL). Additionally, it inhibited the expansion of the cancer cell lines A-549 (human lung), HCT-6 (human colon), and MDAMB (human mammary) (IC50 = 1–10 g/mL) [46]. Serine-threonine protein phosphatase inhibitors have been found as substance 46 and compound 45, its cometabolite [47].
Nortopsentin A–C (48–50) (Figure 10) are a new class of compounds discovered in recent years, isolated by Sun and his colleagues from Bahamas’ deep-water sponge, halihondride sponge Spongosorites ruetzleri [11]. Nortopsentin D (51) is the simplest bis-indole imidazole alkaloid obtained by catalytic hydrogenation of compounds 48–50, the existence of which has been isolated from Halicondride sponge Spongosorites ruetzleri [11]. Pietra and his colleagues reported a new bis-indole alkaloid named nortopsentin E (52), including its separation, structure determination, and biological activity study. The alkaloid is from the deep-water axinellid sponge Dragmacidon sp. collected in the south of New Caledonia [48].
In 1994, Ohta and his colleagues reported the synthesis of compound 51 using a continuous and regioselective di-arylation method, based on the treatment of N-protected 2,4,5-tri- and 4,5-di-bromoimidazole derivatives with N-silylated 3-indolylboric acid in the presence of palladium(0) [49]. Using a similar scheme, in 1996, they performed the total synthesis of compounds 48–51 (Scheme 6, Scheme 7 and Scheme 8 [30]. Many different synthetic routes have been developed to synthesize these compounds [50,51]. Different from the above scheme, Moody and his colleagues developed a new synthetic route, indole-3 carbonamide prepared from the corresponding amide through thioamide were reacted with 3-bromoacetylindole to obtain 2,4-bis(indolyl)imidazole, N-protected compounds 49 and 51 [48].
Nortopsentins have antifungal activity, and some also have antitumor activity. Compared with their parent compound, their methylated derivatives show a significant increase in the biological activity of P388 [49]. Compounds 48–51, tri- and tetramethylated-nortopsentin B in vitro inhibited P388 murine leukemia cells with IC50 of 7.6, 7.8, 1.7, 0.9, and 0.34 µg/mL [11]. In addition to this, in vitro, they inhibited the growth of Bacillus subtilis and Cadida albicans. Compound 50 inhibits the activity of neural nitric oxide synthase and calcineurin, which targets calmodulin, a cofactor shared by the above two enzymes [49]. Activity data show that the brominated compound 49 carrying only one R group is cytotoxic at 0.2 µg/mL, and is more cytotoxic than compound 48 and 50 brominated with two R groups, for P-388 cells, in other words, this change reduces their cytotoxicity to 1.7 µg/mL [30]. Compound 52 is inactive against KB tumor cells, and has almost no antibacterial activity against Staphylococcus aureus. However, after the introduction of methyl groups, although the antibacterial or antifungal activity was not measured, the cytotoxicity towards the KB cell line was highly raised (EC50 = 0.014 µg/mL) [48].
Bartik and his colleagues reported on three new bis-indole alkaloids, topsentin (53), bromotopsentin (54), and deoxytopsentin (55), isolated and determined from the Mediterranean sponge Topsentia genitrix collected near Banyuls, France in 1987 [30]. Compound 53 is the first example of brominated bis-indole alkaloids, whose structural feature is to insert a 2-acylimidazole between two indole units substituted or unsubstituted on the benzene ring [52]. After that, Bartik et al. reported the separation of topsentin alkaloids, and Rinehart and colleagues also published a paper that separated compounds 53 and 54 from Caribbean deep-sea sponges and explained their structure. Moreover, they also discovered another new bis-indole alkaloid 4,5-dihydro-6″-deoxybromotopsentin (56) [53]. Topsentin C (57), a new brominated bisindole alkaloid, was discovered and isolated from the Pacific Ocean sponge Hexadella sp. off the coast of British Columbia [38]. The continued interest in these compounds is undoubtedly influenced by their wide range of biological properties. Capon and his colleagues reported on their chemical research on deep-water Spongosprites sp. collected on the southern Australian coast. In their paper, they introduced isobromotopsentin (58), which had never been reported before [40]. In 1999, four bis-indole alkaloids of topsentins were discovered by Shin’s research team in a sponge Spongosorites genitrix collected from Jaeju island in South Korea, including two new brominated compounds, named bromodeoxytopsentin (59) and isobromodeoxytopsentin (60) [54] (Figure 11).
In 1987, Braekman and his colleagues reported the first total synthesis of compound 55 [52]. In 1988, Rinhert and his colleagues reported the synthesis of compound 53 [53] (Scheme 9). Then, in 2000, under the catalysis of a palladium catalyst, compound 53 was synthesized by cross-coupling reaction at the 5-position of the imidazole ring and acylation at the 2-position [53]. It is believed that the compound 53 molecule is pseudo-symmetric and may be formed by the synthesis of two tryptamine equivalents and the synthon selected in the synthesis is glyoxal indole. If a suitable mixture of indole is selected, it can be condensed with ammonia in equal amounts to obtain the desired asymmetric imidazole (and the other three products), if a single indole is used, a single imidazole is obtained. To confirm the structure of compound 53, Rinehart and his colleagues reported the synthesis of compound 53, whose route is completely different from the route reported by Braekman et al. [53]. As shown in Scheme 9, the total synthesis of compound 53 is achieved by the condensation of 3-glyoxalylindole and 6-benzyloxy-3-glyoxal in the presence of ammonia, but the synthesis yield is low and non-regioselective [53]. After that, Achab reported a new synthetic method that relies on the continuous introduction of indole to functionalized imidazole derivatives [49].
The family of topsentins compounds exhibits diverse and effective biological activities, such as cytotoxicity, anticancer activity, antifungal activity, antiviral activity, and antibacterial activity. Compound 53 can inhibit the proliferation of cultured human and murine tumor cells at a concentration level of µM (IC50 values ranged from 4 to 40 µM) [30]. It shows in vitro activity against P-388 (IC50 = 3 µg/mL) and human tumor cell (HCT-8, A-549, T47D: 20 µg/mL) and in vivo activity against P-388 (T/C 137%, 150 mg/kg) and B16 Melanoma (T/C 144%, 37.5 mg/kg) [55]. In 2020, topsentin’s photoprotective properties on UVB-irradiated human epidermal keratinocyte HaCaT cells were discovered by Hwang et al. Topsentin inhibits the expression of COX-2 and the AP-1 and MAPK upstream signaling pathways. Additionally, topsentin blocks the expression of tumor necrosis factor alpha induced protein 2 (TNF-IP2), a target gene for miR-4485, a novel biomarker chosen from a microarray. A model of reconstructive human skin verified topsentin’s photoprotective effects. These results imply that topsentin might be a good cosmetic formulation candidate for skin inflammatory-mediated disorders [56]. Compounds 54 and 58 showed moderate cytotoxicity to the human leukemia cell line K-562 and the IC50 of 54 and 58 were 0.6 and 2.1 µg/mL, respectively [57]. In addition to anti-tumor activity, compound 54 also has a very effective local anti-inflammatory activity, being a better inhibitor of phospholipase A2 than manoalide [55]. In addition to the above, compounds 53 and 54 also showed good antiviral activity against HSV-1 vesicular stomatitis virus and the coronavirus A-59.
In 1997, caulersin (61) was separated from the alga Caulerpa serrulata and became the first member of the bis-indole alkaloid family, with a functionalized seven-membered ring between two indole molecules [58]. Another of these compounds is caulerpin (62), a bis-indole whose structure is related to compound 61 isolated from several different green and red algae. It can act as a plant growth regulator and has been shown to inhibit algae growth. It acts in the multixenobiotic resistance (MXR) pump in algae, thereby enhancing the toxicity of xenobiotics [30,59,60,61]. In addition, it can also be used as rust inhibitor in low carbon steel [62] (Figure 12).
The synthesis of compound 61 is carried out in seven steps. The construction of the central seven-membered ring is based on the Michael-type addition of 2,3′-bis(indolyl)-ketone to methylvinyl ketone, followed by intramolecular nucleophilic attack of the resulting 3-oxoalkylation product leading to the substitution of the chlorine atom and ring closure [60] (Scheme 10).
In 1977, the synthesis of compound 62 was reported by Maiti et al. It was synthesized from 3-formylindol-2-yl acetic ester with a yield of 5% [61]. Then in 2004, Wahlstrom and his colleagues reported a three-step synthesis of compound 62 [63]. Recently, Mikki and his team reported a four-step synthesis method of compound 61 [64] (Scheme 11). Functional analogues of the bisindole alkaloid compound 62 have been prepared by Canche Chay et al. [65] (Scheme 12). Using as starting materials 5-substituted indoles, the Vilsmeier Haack reaction with POCl3 and DMF forms the corresponding indole aldehyde in good to excellent yields. Subsequent use of dilauroyl peroxide DLP as an oxidative agent which reacts through radical oxidative aromatic substitution of xanthate to produce corresponding malonate derivatives. Further decarboxylation and transesterification reactions between malonate derivatives and NaOMe in MeOH provide monoester indole products. Using piperidine and diethylamine as the base in xylene, the final caulerpin analog can be obtained through the reflux cyclization reaction of monoester indole.
Compounds 61 and 62 have a variety of biological activities. Mao et al. isolated compound 62, caulerpal A (63), and caulerpal B (64) from the Chinese green alga C. taxifolia (Vahl) C. Agardh and tested their inhibitory activity on hPTP1B [66]. The results show that compound 62 has a strong inhibitory activity on PTP1B, IC50 = 3.77 μM, but the inhibitory mechanism has not yet been elucidated.
Caulerpin’s antinociceptive and anti-inflammatory were demonstrated by de Souza et al. Compound 62 significantly inhibited capsaicin induced mouse ear edema by 55.8%, and carrageenan-induced peritonitis by reducing the number of recruit cells by 48.3% [67]. Cavalcante-Silva et al. reported that compound 62 (40 mg/kg) exerts an antinociceptive effect through α2-adrenoceptors and 5-HT3 receptors in the writhing test. Therefore, compound 62 is considered to have the prospect of being developed as a dual-acting target analgesic [68].
Liu et al. reported the anti-tumor activity of compound 62 as a cellular hypoxia-targeted [69]. In an experiment based on T47D cells, compound 62 inhibited hypoxia-induced and 1,10-phenanthroline-induced HIF-1 activation. HIF-1 regulates angiogenic factors, including vascular endothelial growth factor (VEGF).
At the same time, in preliminary tests, compound 62 caused a 100% fatality rate on Culex pipiens mosquito larvae at 500 mg/L. As the age of larvae increased, the toxic effect of compound 62 on larvae decreased slightly. This study shows that compound 63 provides potential mosquito control principles that can be used to develop biological control strategies [70].
Canché Chay and his colleagues evaluated compound 62 and its six analogues as an inhibitor of the growth of the Mycobacterium tuberculosis strain, H37Rv. Compound 63 inhibits Mycobacterium by more than 70% and its IC50 = 0.24 μM. Besides, its activity is more than twice that of rifampin (IC50 = 0.55 μM), which is often used to treat Mycobacterium. Studies have shown that compound 63 is likely to be a potential lead compound for new anti-tuberculosis drugs [65].
In 2013, two new 5-hydroxyindole alkaloids named hyrtinadine B (65) and scalaridine A (66) were isolated from a Dokdo marine sponge Scalarispongia sp. by Lee et al. The cytotoxicity levels of compounds 65 and 66 against human leukemia cells (K562) are IC50 = 215.4 μM and 39.5 μM. Compounds 65 and 66, which are mono- or bis-indoles with heteroaromatic rings, would serve as excellent probes for further research of cancer [71].
Aspertoryadins A–G (67–73), a group of seven novel quinazoline-containing indole alkaloids, were identified from the marine-derived Aspergillus sp. HNMF114 of the bivalve mollusc Sanguinolaria chinensis. Using the techniques previously described, the antibacterial activities of the new compounds against Staphylococcus aureus, Escherichia coli, Bacillus subtilis, and Streptococcus agalactiae as well as the quorum sensing (QS) inhibitory activity against Chromobacterium violaceum CV026 were all assessed. With MIC values of 32 and 32 μg/well, compounds 72 and 73 shown QS inhibitory activity against C. violaceum CV026 [72] (Figure 13).
In 2021, Li et al. discovered one novel pteridine alkaloid, asperpteridinate A, two new prenylated indole alkaloid homodimers, di-6-hydroxydeoxybrevianamide E (74) and dinotoamide J (75), and eleven recognized compounds from the marine-derived fungus Aspergillus austroafricanus Y32-2. Therefore, compound 75 exhibited proangiogenic activity in a PTK787-inducedvascular injury zebrafish model in a dose-dependent manner [73].
Li et al. isolated one new dimeric indole derivative (76) from the sponge-derived actinomycete Rubrobacter radiotolerans. It exhibited the most effective antichlamydial activity with IC50 values of 46.6–96.4 µM in the production of infectious progeny. It appeared to target the mid-stage of the chlamydial developmental cycle by interfering with reticular body replication, but not directly inactivating the infectious elementary body [74].
Antibacterial-guided fractionation of an extract of a deep-water Topsentia sp. marine sponge led to the isolation of two new indole alkaloids, tulongicin A (77) and dihydrospongotine C (78). Compound 77 is the first natural product to contain a di(6-Br-1H-indol-3-yl)methyl group linked to an imidazole core. Both compounds showed strong antimicrobial activity against Staphylococcus aureus (MIC = 1.2 and 3.7 μg/mL) [75] (Figure 14).
Dionemycin (79) and 6-OMe-7′,7′′-dichorochromopyrrolic acid (80), two novel chlorinated bis-indole alkaloids, were discovered from the deep-sea-derived Streptomyces sp. SCSIO 11791. Compound 79 demonstrated anti-staphylococcal activity with a MIC range of 1–2 μg/mL against six clinic strains of methicillin-resistant Staphylococcus aureus (MRSA) obtained from human and pig, according to in vitro antibacterial and cytotoxic studies. Furthermore, compound 79 demonstrated cytotoxic action with an IC50 range of 3.1–11.2 μM against human cancer cell lines NCI-H460, MDA-MB-231, HCT-116, HepG2, and noncancerous MCF10A [76] (Figure 15).

5. Conclusions and Prospect

A valuable source of natural compounds can be found in marine species. Numerous heterocyclic alkaloids and related congeners have been identified and characterized over the past ten years. In recent years, many hetero cyclic alkaloids and congeners with developing value have been derived from them. Most of these indoles have potent cytotoxic activity, and some of them have anti-inflammatory, antifungal, or antiviral activities, making further modification and derivatization of these compounds highly desirable; many derivatives with good activity have been designed and synthesized. In addition, the blank areas of synthetic research on these compounds have been complemented, contributing significantly to their structure–activity studies. Despite the fact that there are more articles about the subject of this review in the literature than ever before, it is reasonable to expect that future research will result in the application of molecules used in clinical treatment.

Author Contributions

Conceptualization, J.S.; writing—original draft preparation, H.S. and K.S.; writing—review and editing, J.S.; funding acquisition, J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Project of Shandong Provincial Natural Science Foundation, China (ZR2020MC032).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Fattorusso, E.; Taglialatela-Scafati, O. Modern Alkaloids: Structure, Isolation, Synthesis and Biology; Wiley-VCH: Weinheim, Germany, 2008. [Google Scholar]
  2. Aygun, A.; Pindur, U. Chemistry and biology of new marine alkaloids from the indole and annelated indole series. Curr. Med. Chem. 2003, 13, 1113–1127. [Google Scholar] [CrossRef] [PubMed]
  3. Jiang, C.S.; Fu, Y.; Zhang, L.; Gong, J.X.; Wang, Z.Z.; Xiao, W.; Zhang, H.Y.; Guo, Y.W. Synthesis and biological evaluation of novel marine-derived indole-based 1,2,4-oxadiazoles derivatives as multifunctional neuroprotective agents. Bioorg. Med. Chem. Lett. 2015, 2, 216–220. [Google Scholar] [CrossRef] [PubMed]
  4. Liu, J.; Li, H.; Chen, K.X.; Zuo, J.P.; Guo, Y.W.; Tang, W.; Li, X.W. Design and synthesis of marine phidianidine derivatives as potential immunosuppressive Agents. J. Med. Chem. 2018, 24, 11298–11308. [Google Scholar] [CrossRef] [PubMed]
  5. Brogan, J.T.; Stoops, S.L.; Lindsley, C.W. Total synthesis and biological evaluation of phidianidines A and B uncovers unique pharmacological profiles at CNS targets. ACS Chem. Neurosci. 2012, 9, 658–664. [Google Scholar] [CrossRef] [Green Version]
  6. Vitale, R.M.; Gatti, M.; Carbone, M.; Barbieri, F.; Felicita, V.; Gavagnin, M.; Florio, T.; Amodeo, P. Minimalist hybrid ligand/receptor-based pharmacophore model for CXCR4 applied to a small-library of marine natural products led to the identification of phidianidine a as a new CXCR4 ligand exhibiting antagonist activity. ACS Chem. Biol. 2013, 12, 2762–2770. [Google Scholar] [CrossRef]
  7. Labriere, C.; Elumalai, V.; Staffansson, J.; Cervin, G.; Le Norcy, T.; Denardou, H.; Rehel, K.; Moodie, L.W.K.; Hellio, C.; Pavia, H.; et al. Phidianidine A and synthetic analogues as naturally inspired marine antifoulants. J. Nat. Prod. 2020, 11, 3413–3423. [Google Scholar] [CrossRef]
  8. Zhou, L.M.; Kong, F.D.; Fan, P.; Ma, Q.Y.; Xie, Q.Y.; Li, J.H.; Zheng, H.Z.; Zheng, Z.H.; Yuan, J.Z.; Dai, H.F.; et al. Indole-diterpenoids with protein tyrosine phosphatase inhibitory activities from the marine-derived fungus Penicillium sp. KFD28. J. Nat. Prod. 2019, 9, 2638–2644. [Google Scholar] [CrossRef]
  9. Chen, M.Y.; Xie, Q.Y.; Kong, F.D.; Ma, Q.Y.; Zhou, L.M.; Yuan, J.Z.; Dai, H.F.; Wu, Y.G.; Zhao, Y.X. Two new indole-diterpenoids from the marine-derived fungus Penicillium sp. KFD28. J. Asian Nat. Prod. Res. 2021, 11, 1030–1036. [Google Scholar] [CrossRef]
  10. Zhang, Y.H.; Geng, C.; Zhang, X.W.; Zhu, H.J.; Shao, C.L.; Cao, F.; Wang, C.Y. Discovery of bioactive indole-diketopiperazines from the marine-derived fungus penicillium brasilianum aided by genomic information. Mar. Drugs 2019, 9, 514. [Google Scholar] [CrossRef] [Green Version]
  11. Sakemi, S.; Sun, H.H. Nortopsentins A, B, and C. Cytotoxic and antifungal imidazolediylbis[indoles] from the sponge Spongosorites ruetzleri. J. Org. Chem. 1991, 13, 4304–4307. [Google Scholar] [CrossRef]
  12. Paul, G.K.; Gunasekera, S.P.; Longley, R.E.; Pomponi, S.A. Theopederins K and L. Highly potent cytotoxic metabolites from a marine sponge Discodermia species. J. Nat. Prod. 2002, 1, 59–61. [Google Scholar] [CrossRef] [PubMed]
  13. Capon, R.J.; Peng, C.; Dooms, C. Trachycladindoles A-G: Cytotoxic heterocycles from an Australian marine sponge, Trachycladus laevispirulifer. Org. Biomol. Chem. 2008, 15, 2765–2771. [Google Scholar] [CrossRef]
  14. Narkowicz, C.K.; Blackman, A.J.; Lacey, E.; Gill, J.H.; Heiland, K. Convolutindole A and convolutamine H, new nematocidal brominated alkaloids from the marine bryozoan Amathia convoluta. J. Nat. Prod. 2002, 6, 938–941. [Google Scholar] [CrossRef] [PubMed]
  15. Zhou, G.; Sun, C.; Hou, X.; Che, Q.; Zhang, G.; Gu, Q.; Liu, C.; Zhu, T.; Li, D. Ascandinines A-D, indole diterpenoids, from the Sponge-Derived Fungus Aspergillus candidus HDN15-152. J. Org. Chem. 2021, 3, 2431–2436. [Google Scholar] [CrossRef] [PubMed]
  16. Gompel, M.; Leost, M.; De Kier Joffe, E.B.; Puricelli, L.; Franco, L.H.; Palermo, J.; Meijer, L. Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum. Bioorg. Med. Chem. Lett. 2004, 7, 1703–1707. [Google Scholar] [CrossRef] [PubMed]
  17. Kruppa, M.; Sommer, G.A.; Muller, T.J.J. Concise syntheses of marine (bis)indole alkaloids meridianin C, D, F, and G and scalaridine A via one-pot Masuda borylation-Suzuki coupling sequence. Molecules 2022, 7, 2233. [Google Scholar] [CrossRef]
  18. Olsen, E.K.; Hansen, E.; Isaksson, J.; Sepcic, K.; Cergolj, M.; Svenson, J.; Andersen, J.H. Marine AChE inhibitors isolated from Geodia barretti: Natural compounds and their synthetic analogs. Org. Biomol. Chem. 2016, 5, 1629–1640. [Google Scholar] [CrossRef]
  19. Longeon, A.; Copp, B.R.; Quevrain, E.; Roue, M.; Kientz, B.; Cresteil, T.; Petek, S.; Debitus, C.; Bourguet-Kondracki, M.L. Bioactive indole derivatives from the South Pacific marine sponges Rhopaloeides odorabile and Hyrtios sp. Mar. Drugs 2011, 5, 879–888. [Google Scholar] [CrossRef] [Green Version]
  20. Liu, L.; Xu, W.; Li, S.; Chen, M.; Cheng, Y.; Yuan, W.; Cheng, Z.; Li, Q. Penicindopene A, a new indole diterpene from the deep-sea fungus Penicillium sp. YPCMAC1. Nat. Prod. Res. 2019, 20, 2988–2994. [Google Scholar] [CrossRef]
  21. Youssef, D.T.; Shaala, L.A.; Asfour, H.Z. Bioactive compounds from the Red Sea marine sponge Hyrtios species. Mar. Drugs 2013, 4, 1061–1070. [Google Scholar] [CrossRef] [Green Version]
  22. Limbadri, S.; Luo, X.; Lin, X.; Liao, S.; Wang, J.; Zhou, X.; Yang, B.; Liu, Y. Bioactive Novel Indole Alkaloids and Steroids from Deep Sea-Derived Fungus Aspergillus fumigatus SCSIO 41012. Molecules 2018, 23, 2379. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Akiyama, H.; Oku, N.; Kasai, H.; Shizuri, Y.; Matsumoto, S.; Igarashi, Y. Metabolites from thermophilic bacteria I: N-propionylanthranilic acid, a co-metabolite of the bacillamide class antibiotics and tryptophan metabolites with herbicidal activity from Laceyella sacchari. J. Antibiot. 2014, 11, 795–798. [Google Scholar] [CrossRef] [PubMed]
  24. Gebhardt, K.; Schimana, J.; Muller, J.; Fiedler, H.P.; Kallenborn, H.G.; Holzenkampfer, M.; Krastel, P.; Zeeck, A.; Vater, J.; Holtzel, A.; et al. Screening for biologically active metabolites with endosymbiotic bacilli isolated from arthropods. FEMS Microbiol. Lett. 2002, 2, 199–205. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Socha, A.M.; Long, R.A.; Rowley, D.C. Bacillamides from a hypersaline microbial mat bacterium. J. Nat. Prod. 2007, 11, 1793–1795. [Google Scholar] [CrossRef] [PubMed]
  26. Greshock, T.J.; Grubbs, A.W.; Jiao, P.; Wicklow, D.T.; Gloer, J.B.; Williams, R.M. Isolation, structure elucidation, and biomimetic total synthesis of versicolamide B, and the isolation of antipodal (-)-stephacidin A and (+)-notoamide B from Aspergillus versicolor NRRL 35600. Angew. Chem. Int. Ed. Engl. 2008, 19, 3573–3577. [Google Scholar] [CrossRef] [PubMed]
  27. Kagiyama, I.; Kato, H.; Nehira, T.; Frisvad, J.C.; Sherman, D.H.; Williams, R.M.; Tsukamoto, S. Taichunamides: Prenylated Indole Alkaloids from Aspergillus taichungensis (IBT 19404). Angew. Chem. Int. Ed. Engl. 2016, 3, 1128–1132. [Google Scholar] [CrossRef] [Green Version]
  28. Zhang, P.; Li, X.M.; Wang, J.N.; Li, X.; Wang, B.G. Prenylated indole alkaloids from the marine-derived fungus Paecilomyces variotii. Chin. Chem. Lett. 2015, 20, 3374–3376. [Google Scholar] [CrossRef]
  29. Li, H.; Sun, W.; Deng, M.; Zhou, Q.; Wang, J.; Liu, J.; Chen, C.; Qi, C.; Luo, Z.; Xue, Y.; et al. Asperversiamides, Linearly Fused Prenylated Indole Alkaloids from the Marine-Derived Fungus Aspergillus versicolor. J. Org. Chem. 2018, 15, 8483–8492. [Google Scholar] [CrossRef]
  30. Gupta, L.; Talwar, A.; Chauhan, P.M. Bis and tris indole alkaloids from marine organisms: New leads for drug discovery. Curr. Med. Chem. 2007, 16, 1789–1803. [Google Scholar] [CrossRef]
  31. Gunasekera, S.P.; McCarthy, P.J.; Kelly-Borges, M. Hamacanthins A and B, new antifungal bis indole alkaloids from the deep-water marine sponge, Hamacantha sp. J. Nat. Prod. 1994, 10, 1437–1441. [Google Scholar] [CrossRef]
  32. Bao, B.; Sun, Q.; Yao, X.; Hong, J.; Lee, C.O.; Sim, C.J.; Im, K.S.; Jung, J.H. Cytotoxic bisindole alkaloids from a marine sponge Spongosorites sp. J. Nat. Prod. 2005, 68, 711–715. [Google Scholar] [CrossRef] [PubMed]
  33. Kouko, T.; Matsumura, K.; Kawasaki, T. Total synthesis of marine bisindole alkaloids, (+)-hamacanthins A, B and (−)-antipode of cis-dihydrohamacanthin B. Tetrahedron 2005, 9, 2309–2318. [Google Scholar] [CrossRef]
  34. Golantsov, N.E.; Festa, A.A.; Karchava, A.V.; Yurovskaya, M.A. ChemInform Abstract: Marine Indole Alkaloids Containing an 1-(Indol-3-yl)ethane-1,2-diamine Fragment. ChemInform 2013, 37, 1537–1540. [Google Scholar] [CrossRef]
  35. Oh, K.B.; Mar, W.; Kim, S.; Kim, J.Y.; Lee, T.H.; Kim, J.G.; Shin, D.; Sim, C.J.; Shin, J. Antimicrobial activity and cytotoxicity of bis(indole) alkaloids from the sponge Spongosorites sp. Biol. Pharm. Bull. 2006, 3, 570–573. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Kohmoto, S.; Kashman, Y.; McConnell, O.J.; Rinehart, K.L.J.; Wright, A.; Koehn, F. ChemInform Abstract: Dragmacidin, a New Cytotoxic Bis(indole) Alkaloid from a Deep Water Marine Sponge, Dragmacidon sp. ChemInform 1988, 13, 3116–3118. [Google Scholar] [CrossRef]
  37. Crooke, S.; Whitlock, C. A general synthesis of bis-indolylpiperazine-2,5-diones. Molecules 2012, 12, 14841–14845. [Google Scholar] [CrossRef] [Green Version]
  38. Morris, S.A.; Andersen, R.J. Brominated bis(indole) alkaloids from the marine sponge Hexadella sp. Tetrahedron 1990, 46, 715–720. [Google Scholar] [CrossRef]
  39. Fahy, E.; Porn, B.; Smith, K. 6-bromotryptamine derivatives from the gulf of california tunicate dzdemnum candzdum. J. Nat. Prod. 1991, 46, 1192–1194. [Google Scholar]
  40. Murray, L.M.; Lim, T.K.; Hooper, J.N.A.; Capon, R.J. Isobromotopsentin: A New Bis(indole) Alkaloid From a Deep-Water Marine Sponge Spongosorites sp. Aust. J. Chem. 1995, 12, 2053–2058. [Google Scholar] [CrossRef]
  41. Cutignano, A.; Bifulco, G.; Bruno, I.; Casapullo, A.; Gomez-Paloma, L.; Riccio, R. Dragmacidin F: A new antiviral bromoindole alkaloid from the Mediterranean Sponge Halicortex sp. Tetrahedron 2000, 23, 3743–3748. [Google Scholar] [CrossRef]
  42. Jiang, B.; Smallheer, J.M.; Amaral-Ly, C.; Wuonola, M.A. Total Synthesis of (.+−.)-Dragmacidin: A cytotoxic bis(indole)alkaloid of marine origin. J. Org. Chem. 2002, 22, 6823–6827. [Google Scholar] [CrossRef]
  43. Whitlock, C.R.; Cava, M.P. A total synthesis of dragmacidin B. Tetrahedron 1994, 3, 371–374. [Google Scholar] [CrossRef]
  44. Miyake, F.Y.; Yakushijin, K.; Horne, D.A. Biomimetic synthesis of grossularines-1. Angew. Chem. Int. Ed. Engl. 2005, 21, 3280–3282. [Google Scholar] [CrossRef] [PubMed]
  45. Kawasaki, T.; Enoki, H.; Matsumura, K.; Ohyama, M.; Inagawa, M.; Sakamoto, M. First total synthesis of dragmacidin A via indolylglycines. Org. Lett. 2000, 19, 3027–3029. [Google Scholar] [CrossRef]
  46. Garg, N.K.; Stoltz, B.M. The formal total synthesis of Dragmacidin B, trans-Dragmacidin C, and cis- and trans-dihydrohamacanthins A. Tetrahedron Lett. 2005, 14, 2423–2426. [Google Scholar] [CrossRef]
  47. Capon, R.J.; Rooney, F.; Murray, L.M.; Collins, E.; Sim, A.T.R.; Rostas, J.A.P.; Butler, M.S.; Carroll, A.R. Dragmacidins: New protein phosphatase inhibitors from a southern australian deep-water marine sponge, Spongosorites sp. J. Nat. Prod. 1998, 5, 660–662. [Google Scholar] [CrossRef]
  48. Mancini, I.; Guella, G.; Pietra, F.; Debitus, C.C.; Waikedre, J. From inactive nortopsentin D, a novel bis(indole) alkaloid isolated from the Axinellid Sponge Dragmacidon sp. from deep waters south of new caledonia, to a strongly cytotoxic derivative. Helv. Chim. Acta. 1996, 8, 2075–2082. [Google Scholar] [CrossRef]
  49. Yang, C.G.; Huang, H.; Jiang, B. Progress in studies of novel marine bis(indole) alkaloids. Curr. Org. Chem. 2004, 17, 1691–1720. [Google Scholar] [CrossRef]
  50. Ramsden, C.A.; Moody, C.J.; Roffey, J.R.A. Synthesis of N-protected nortopsentins B and D. Arkivoc 2000, 3, 393–401. [Google Scholar]
  51. Fresneda, P.M.; Molina, P.; Sanz, M.A.J.S. The first synthesis of the bis(indole) marine alkaloid Rhopaladin D. Synlett. 2000, 7, 1691–1720. [Google Scholar]
  52. Braekman, J.C.; Daloze, D.; Stoller, C. Synthesis of Topsentin-A, abisindole alkaloid of the marine sponge topsentia genitrix. Bull. Des Sociétés Chim. Belg. 2010, 10, 809–812. [Google Scholar] [CrossRef]
  53. Tsujii, S.; Rinehart, K.L.; Gunasekera, S.P.; Kashman, Y.; Cross, S.S.; Lui, M.S.; Pomponi, S.A.; Diaz, M.C. Topsentin, bromotopsentin, and dihydrodeoxybromotopsentin: Antiviral and antitumor bis(indolyl)imidazoles from Caribbean deep-sea sponges of the family Halichondriidae. Structural and synthetic studies. J. Org. Chem. 2002, 23, 5446–5453. [Google Scholar] [CrossRef]
  54. Shin, J.; Seo, Y.; Cho, K.W.; Rho, J.R.; Sim, C.J. New Bis(Indole) alkaloids of the topsentin class from the sponge spongosorites genitrix. J. Nat. Prod. 1999, 4, 647–649. [Google Scholar] [CrossRef] [PubMed]
  55. Wylie, B.L.; Ernst, N.B.; Grace, K.J.S.; Jacobs, R.S. Marine Natural Products as Phospholipase A2 Inhibitors. Prog. Surg. 1997, 24, 146–152. [Google Scholar]
  56. Hwang, J.; Kim, D.; Park, J.S.; Park, H.J.; Shin, J.; Lee, S.K. Photoprotective activity of Topsentin, A bis(indole) alkaloid from the marine sponge Spongosorites genitrix, by regulation of COX-2 and Mir-4485 expression in UVB-irradiated human keratinocyte cells. Mar. Drugs 2020, 18, 87. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Casapullo, A.; Bifulco, G.; Bruno, I.; Riccio, R. New bisindole alkaloids of the topsentin and hamacanthin classes from the Mediterranean marine sponge Rhaphisia lacazei. J. Nat. Prod. 2000, 4, 447–451. [Google Scholar] [CrossRef]
  58. Su, J.Y.; Zhu, Y.; Zeng, L.M.; Xu, X.H. A new bisindole from Alga Caulerpa serrulata. J. Nat. Prod. 1997, 10, 1043–1044. [Google Scholar] [CrossRef]
  59. Pindur, U.; Lemster, T. Advances in marine natural products of the indole and annelated indole series: Chemical and biological aspects. Curr. Med. Chem. 2001, 13, 1681–1698. [Google Scholar] [CrossRef]
  60. Fresneda, P.M.; Molina, P.; Angeles Saez, M. The first synthesis of the bis(indole) marine alkaloid Caulersin. Synlett 1999, 10, 1651–1653. [Google Scholar] [CrossRef]
  61. Maiti, B.C.; Thomson, R.H.; Mahendran, M. Structure of Caulerpin, a Pigmet from Caulerpa Algae. J. Chem. Res. 1978, 4, 126–127. [Google Scholar]
  62. Lunagariya, J.; Bhadja, P.; Zhong, S.; Vekariya, R.; Xu, S. Marine natural product bis-indole alkaloid Caulerpin: Chemistry and biology. MiniRev. Med. Chem. 2019, 9, 751–761. [Google Scholar] [CrossRef] [PubMed]
  63. Wahlström, N.; Stensland, B.; Bergman, J. Synthesis of the marine alkaloid Caulersin. Tetrahedron 2004, 9, 2147–2153. [Google Scholar] [CrossRef]
  64. Miki, Y.; Aoki, Y.; Miyatake, H.; Minematsu, T.; Hibino, H. Synthesis of caulersin and its isomers by reaction of indole-2,3-dicarboxylic anhydrides with methyl indoleacetates. Tetrahedron Lett. 2006, 29, 5215–5218. [Google Scholar] [CrossRef]
  65. Canche Chay, C.I.; Gomez Cansino, R.; Espitia Pinzon, C.I.; Torres-Ochoa, R.O.; Martinez, R. Synthesis and anti-tuberculosis activity of the marine natural product Caulerpin and its analogues. Mar. Drugs 2014, 4, 1757–1772. [Google Scholar] [CrossRef] [Green Version]
  66. Mao, S.C.; Guo, Y.W.; Shen, X. Two novel aromatic valerenane-type sesquiterpenes from the Chinese green alga Caulerpa taxifolia. Bioorg. Med. Chem. Lett. 2006, 11, 2947–2950. [Google Scholar] [CrossRef]
  67. de Souza, E.T.; de Lira, D.P.; de Queiroz, A.C.; da Silva, D.J.; de Aquino, A.B.; Mella, E.A.; Lorenzo, V.P.; de Miranda, G.E.; de Araujo-Junior, J.X.; Chaves, M.C.; et al. The antinociceptive and anti-inflammatory activities of caulerpin, a bisindole alkaloid isolated from seaweeds of the genus Caulerpa. Mar. Drugs 2009, 7, 689–704. [Google Scholar] [CrossRef] [Green Version]
  68. Cavalcante-Silva, L.H.; de Carvalho Correia, A.C.; Barbosa-Filho, J.M.; da Silva, B.A.; de Oliveira Santos, B.V.; de Lira, D.P.; Sousa, J.C.; de Miranda, G.E.; de Andrade Cavalcante, F.; Alexandre-Moreira, M.S. Spasmolytic effect of caulerpine involves blockade of Ca2+ influx on guinea pig ileum. Mar. Drugs 2013, 5, 1553–1564. [Google Scholar] [CrossRef] [Green Version]
  69. Liu, Y.; Morgan, J.B.; Coothankandaswamy, V.; Liu, R.; Jekabsons, M.B.; Mahdi, F.; Nagle, D.G.; Zhou, Y.D. The Caulerpa pigment caulerpin inhibits HIF-1 activation and mitochondrial respiration. J. Nat. Prod. 2009, 12, 2104–2109. [Google Scholar] [CrossRef] [Green Version]
  70. Alarif, W.M.; Abou-Elnaga, Z.S.; Ayyad, S.E.N.; Al-lihaibi, S.S. Insecticidal metabolites from the Green Alga Caulerpa racemosa. CLEAN-Soil Air Water 2010, 38, 548–557. [Google Scholar] [CrossRef]
  71. Lee, Y.J.; Lee, D.G.; Rho, H.S.; Krasokhin, V.B.; Shin, H.J.; Lee, J.S.; Lee, H.S. Cytotoxic 5-hydroxyindole alkaloids from the marine sponge Scalarispongia sp. J. Heterocycl. Chem. 2013, 6, 1400–1404. [Google Scholar] [CrossRef]
  72. Kong, F.D.; Zhang, S.L.; Zhou, S.Q.; Ma, Q.Y.; Xie, Q.Y.; Chen, J.P.; Li, J.H.; Zhou, L.M.; Yuan, J.Z.; Hu, Z.; et al. Quinazoline-containing indole alkaloids from the marine-derived fungus Aspergillus sp. HNMF114. J. Nat. Prod. 2019, 12, 3456–3463. [Google Scholar] [CrossRef] [PubMed]
  73. Li, P.; Zhang, M.; Li, H.; Wang, R.; Hou, H.; Li, X.; Liu, K.; Chen, H. New prenylated indole homodimeric and pteridine alkaloids from the marine-derived fungus Aspergillus austroafricanus Y32-2. Mar. Drugs 2021, 19, 98. [Google Scholar] [CrossRef] [PubMed]
  74. Li, J.L.; Chen, D.; Huang, L.; Ni, M.; Zhao, Y.; Fan, H.; Bao, X. Antichlamydial dimeric indole derivatives from marine actinomycete Rubrobacter radiotolerans. Planta Med. 2017, 9, 805–811. [Google Scholar] [CrossRef] [PubMed]
  75. Liu, H.B.; Lauro, G.; O’Connor, R.D.; Lohith, K.; Kelly, M.; Colin, P.; Bifulco, G.; Bewley, C.A. Tulongicin, an antibacterial tri-indole alkaloid from a deep-water Topsentia sp. Sponge. J. Nat. Prod. 2017, 9, 2556–2560. [Google Scholar] [CrossRef] [PubMed]
  76. Song, Y.; Yang, J.; Yu, J.; Li, J.; Yuan, J.; Wong, N.K.; Ju, J. Chlorinated bis-indole alkaloids from deep-sea derived Streptomyces sp. SCSIO 11791 with antibacterial and cytotoxic activities. J. Antibiot. 2020, 8, 542–547. [Google Scholar] [CrossRef] [PubMed]
Molecules 28 02204 sch001 550
Scheme 1. The total synthesis of phidianidines A (1) and B (2).
Scheme 1. The total synthesis of phidianidines A (1) and B (2).
Molecules 28 02204 sch001
Molecules 28 02204 g001 550
Figure 1. The structure of compounds 1–12.
Figure 1. The structure of compounds 1–12.
Molecules 28 02204 g001
Molecules 28 02204 g002 550
Figure 2. The structure of compounds 13a–14g.
Figure 2. The structure of compounds 13a–14g.
Molecules 28 02204 g002
Molecules 28 02204 g003 550
Figure 3. The structure of compounds 15–19.
Figure 3. The structure of compounds 15–19.
Molecules 28 02204 g003
Molecules 28 02204 sch002 550
Scheme 2. Synthesis of meridianins C, D, F, and G (20c, d, f, and g) via one-pot Masuda borylation-Suzuki coupling sequence.
Scheme 2. Synthesis of meridianins C, D, F, and G (20c, d, f, and g) via one-pot Masuda borylation-Suzuki coupling sequence.
Molecules 28 02204 sch002
Molecules 28 02204 g004 550
Figure 4. The structure of compounds 20a–26c.
Figure 4. The structure of compounds 20a–26c.
Molecules 28 02204 g004
Molecules 28 02204 g005 550
Figure 5. The structure of fumigatosides E and F (27a,b).
Figure 5. The structure of fumigatosides E and F (27a,b).
Molecules 28 02204 g005
Molecules 28 02204 g006 550
Figure 6. The structures of compounds 28a–29b.
Figure 6. The structures of compounds 28a–29b.
Molecules 28 02204 g006
Molecules 28 02204 sch003 550
Scheme 3. The total synthesis of two N-acylanthranillic acids (28a,b).
Scheme 3. The total synthesis of two N-acylanthranillic acids (28a,b).
Molecules 28 02204 sch003
Molecules 28 02204 g007 550
Figure 7. The structure of compounds 30–38.
Figure 7. The structure of compounds 30–38.
Molecules 28 02204 g007
Molecules 28 02204 g008 550
Figure 8. Structures of hamacanthin A and hamacanthin B (39,40).
Figure 8. Structures of hamacanthin A and hamacanthin B (39,40).
Molecules 28 02204 g008
Molecules 28 02204 sch004 550
Scheme 4. The total synthesis of hamacanthin A and hamacanthin B (39,40).
Scheme 4. The total synthesis of hamacanthin A and hamacanthin B (39,40).
Molecules 28 02204 sch004
Molecules 28 02204 g009 550
Figure 9. Structures of dragmacidin and dragmacidin A–F (41–47).
Figure 9. Structures of dragmacidin and dragmacidin A–F (41–47).
Molecules 28 02204 g009
Molecules 28 02204 sch005 550
Scheme 5. The total synthesis of dragmacidin (41).
Scheme 5. The total synthesis of dragmacidin (41).
Molecules 28 02204 sch005
Molecules 28 02204 g010 550
Figure 10. Structures of nortopsentin A–E (48–52).
Figure 10. Structures of nortopsentin A–E (48–52).
Molecules 28 02204 g010
Molecules 28 02204 sch006 550
Scheme 6. The synthesis of nortopsentin A (48) and nortopsentin B (49).
Scheme 6. The synthesis of nortopsentin A (48) and nortopsentin B (49).
Molecules 28 02204 sch006
Molecules 28 02204 sch007 550
Scheme 7. The synthesis of nortopsentin C (50).
Scheme 7. The synthesis of nortopsentin C (50).
Molecules 28 02204 sch007
Molecules 28 02204 sch008 550
Scheme 8. The synthesis of nortopsentin D (51).
Scheme 8. The synthesis of nortopsentin D (51).
Molecules 28 02204 sch008
Molecules 28 02204 g011 550
Figure 11. Structures of Compounds 53–60.
Figure 11. Structures of Compounds 53–60.
Molecules 28 02204 g011
Molecules 28 02204 sch009 550
Scheme 9. The synthesis of topsentin (53).
Scheme 9. The synthesis of topsentin (53).
Molecules 28 02204 sch009
Molecules 28 02204 g012 550
Figure 12. Structures of compounds 61–64.
Figure 12. Structures of compounds 61–64.
Molecules 28 02204 g012
Molecules 28 02204 sch010 550
Scheme 10. The synthesis of caulersin (61).
Scheme 10. The synthesis of caulersin (61).
Molecules 28 02204 sch010
Molecules 28 02204 sch011 550
Scheme 11. The four-step synthesis method of compound 61.
Scheme 11. The four-step synthesis method of compound 61.
Molecules 28 02204 sch011
Molecules 28 02204 sch012 550
Scheme 12. The four-step synthesis method of compound 62.
Scheme 12. The four-step synthesis method of compound 62.
Molecules 28 02204 sch012
Molecules 28 02204 g013 550
Figure 13. The structure of compounds 65–73.
Figure 13. The structure of compounds 65–73.
Molecules 28 02204 g013
Molecules 28 02204 g014 550
Figure 14. The structure of compounds 74–78.
Figure 14. The structure of compounds 74–78.
Molecules 28 02204 g014
Molecules 28 02204 g015 550
Figure 15. The structure of compounds 79,80.
Figure 15. The structure of compounds 79,80.
Molecules 28 02204 g015
Table
Table 1. Cancer cell line inhibition by hyrtioerectines D-F (26a–26c).
Table 1. Cancer cell line inhibition by hyrtioerectines D-F (26a–26c).
CompoundCell Line (GI50 (μM))
MDA-MB-231A549HT-29
26a253028
26b9010085
26c423545
Doxorubicin a0.300.350.40
a Positive antiproliferative control.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sun, H.; Sun, K.; Sun, J. Recent Advances of Marine Natural Indole Products in Chemical and Biological Aspects. Molecules 2023, 28, 2204. https://doi.org/10.3390/molecules28052204

AMA Style

Sun H, Sun K, Sun J. Recent Advances of Marine Natural Indole Products in Chemical and Biological Aspects. Molecules. 2023; 28(5):2204. https://doi.org/10.3390/molecules28052204

Chicago/Turabian Style

Sun, Haoyi, Kangping Sun, and Jingyong Sun. 2023. "Recent Advances of Marine Natural Indole Products in Chemical and Biological Aspects" Molecules 28, no. 5: 2204. https://doi.org/10.3390/molecules28052204

APA Style

Sun, H., Sun, K., & Sun, J. (2023). Recent Advances of Marine Natural Indole Products in Chemical and Biological Aspects. Molecules, 28(5), 2204. https://doi.org/10.3390/molecules28052204

Article Metrics

Back to TopTop